Yata Kazuya, Beder Levent Bekir, Tamagawa Shunji, Hotomi Muneki, Hirohashi Yoshihiko, Grenman Reidar, Yamanaka Noboru
Department of Otolaryngology-Head and Neck Surgery, Wakayama Medical University, Wakayama 641-8509, Japan.
Department of Pathology, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo, Japan.
Int J Oncol. 2015 Oct;47(4):1249-56. doi: 10.3892/ijo.2015.3145. Epub 2015 Aug 31.
Increasing evidence indicates that cancer stem cells have essential roles in tumor initiation, progression, metastasis and resistance to chemo-radiation. Recent research has pointed out biological importance of microRNAs in cancer stem cell dysregulation. Total number of mature microRNAs in human genome increased to more than 2,500 with the recent up-date of the database. However, currently no information is available regarding microRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma (HNSCC). Increased ALDH1 activity has been demonstrated as a reliable marker for isolation of cancer stem cells. Therefore, we evaluated the microRNA expression profile of ALDH1-high subpopulations in the HNSCC cell lines UTSCC-9 and UTSCC-90. Initially, we examined cancer stem cell properties of ALDH1-high subpopulations in both cell lines. We analyzed expression of stemness markers, sphere formation capacity and xenograft transplantation into NOD/SCID mice. Our findings validated that ALDH1-high subpopulations showed significantly increased tumor-initiating ability. Furthermore, we investigated the microRNA expression profile of HNSCC stem cells using microRNA array and confirmed the results by quantitative real-time PCR. We found that expressions of miR‑424, let-7a, miR‑6836, miR‑6873 and miR‑7152 were downregulated, whereas miR‑147b was upregulated with statistical significance in the ALDH1-high subpopulation. In conclusion, we identified a subset of microRNAs that were differentially expressed in ALDH1-high subpopulation, providing new microRNA targets to study dysregulation of HNSCC-initiating cells and develop therapeutic strategies aimed at eradicating the tumorigenic stem cells in HNSCC.
越来越多的证据表明,癌症干细胞在肿瘤起始、进展、转移及放化疗抵抗中发挥着重要作用。近期研究指出了微小RNA在癌症干细胞失调中的生物学重要性。随着数据库的最新更新,人类基因组中成熟微小RNA的总数增加到了2500多种。然而,目前尚无关于头颈部鳞状细胞癌(HNSCC)中癌症干细胞微小RNA表达谱的信息。已证实醛脱氢酶1(ALDH1)活性增加是分离癌症干细胞的可靠标志物。因此,我们评估了HNSCC细胞系UTSCC-9和UTSCC-90中ALDH1高表达亚群的微小RNA表达谱。首先,我们检测了这两种细胞系中ALDH1高表达亚群的癌症干细胞特性。我们分析了干性标志物的表达、成球能力以及移植到NOD/SCID小鼠体内的异种移植情况。我们的研究结果证实,ALDH1高表达亚群显示出显著增强的肿瘤起始能力。此外,我们使用微小RNA芯片研究了HNSCC干细胞的微小RNA表达谱,并通过定量实时PCR证实了结果。我们发现,在ALDH1高表达亚群中,miR-424、let-7a、miR-6836、miR-6873和miR-7152的表达下调,而miR-147b的表达上调,且具有统计学意义。总之,我们鉴定出了一组在ALDH1高表达亚群中差异表达的微小RNA,为研究HNSCC起始细胞的失调及制定旨在根除HNSCC中致瘤干细胞的治疗策略提供了新的微小RNA靶点。